Effects of Spinal Cord Stimulation on Gait in Patients With Parkinson´s Disease
Key facts
- Who runs it
- University of Sao Paulo General Hospital
- Where
- Brazil1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 8 people enrolled
- Started
- 30 Nov 2021
- Ended
- 1 Mar 2024
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Active spinal cord stimulation
- Sham spinal cord stimulation
- Record updated
- 13 May 2024
- Why it stopped
- No effect identified with two thirds of expected sample size completing study, one patient presented adverse perioperative event.
Who can take part
- Age
- 21 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Diagnosed Parkinson´s Disease with Hoehn Yahr scale between 2,5 and 4,0
- Main complaint of balance or freezing of gait
- Score of 2 or more on subitem 3.11 of the MDS UPDRS scale concerning Freezing of Gait severity
- Capable of informed consent
Who cannot take part
- Uncontrolled or serious comorbidities such as uncontrolled diabetes mellitus, renal disease, anticoagulation, immunosuppression or other medical conditions that present a contraindication for SCS surgery
- Psychosis, uncontrolled depression (BDI >14) or anxiety disorder (BAI >14)
- Frequent lower limb, lower back or hip pain scoring 3 or more on visual analog scale
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Spinal cord stimulation (SCS) for Parkinson´s disease (PD) has been studied for a decade but consensus on efficacy is still lacking, with the previous stimulation standard paresthesia inducing threshold hampering adequate subject blinding. Considering that tonic stimulation for pain has been shown to be efficacious for most patients on subthreshold stimulation parameters we hypothesize a similar result with it´s use on PD. The investigators aim to:
Read full original descriptionShow less
1. Produce stronger evidence on SCS efficacy for PD in regards to gait, motor scores and quality of life measures by incorporating subthreshold in a randomized cross over placebo-controlled study with a large sample. 2. Identify predictors of good response to SCS therapy by performing trans spinal magnetic stimulation (TSMS) before SCS implant and correlating the response to SCS to that of the noninvasive TSMS. 3. Better provide biomarkers of SCS therapy through functional magnetic resonance imaging and electroencephalographic mapping.
The 2 groups in the trial
- Active stimulationTreatment being tested
During active stimulation phase, patients will receive through the spinal cord stimulator active tonic stimulation with amplitude set to 90% of paresthesia inducing threshold, therefore allowing blinding. Patients will be evaluated after a three week wash out period with no stimulation and after three weeks of continuous active stimulation.
Treatment: Active spinal cord stimulation
- Sham stimulationSham treatment, for comparison
During sham stimulation phase, patients will receive through the spinal cord stimulator a zero amplitude stimulation, therefore having no electrical current passing through epidural leads but with the program status still displayed as "on" if checked with patient's personal controller. Patients will be evaluated after a three week wash out period with no stimulation and after three weeks of continuous sham stimulation.
Treatment: Sham spinal cord stimulation
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effects of Spinal Cord Stimulation on Gait in Patients With Parkinson´s Disease; a Randomized, Crossover, Double Blinded, Placebo-Controlled Study
- Record updated
- 13 May 2024